Posts tagged "with-inflammation"

Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on …

HAYWARD, Calif., March 22, 2013 /PRNewswire/ – Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune …

Read more...

Be the first to comment - What do you think?
Posted by admin - March 22, 2013 at 12:00 pm

Categories: Uncategorized   Tags: , , , , , , , ,

Too much salt may trigger autoimmune diseases

Increased salt consumption may be a key culprit behind rising rates of autoimmune diseases such as multiple sclerosis, researchers reported on Wednesday in a trio of papers looking at the role of a specific class of cells linked with inflammation.

Read more...

Be the first to comment - What do you think?
Posted by admin - March 7, 2013 at 2:08 am

Categories: Uncategorized   Tags: , , , , , , , , , , , , , ,

Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference

HAYWARD, Calif., Feb. 7, 2013 /PRNewswire/ – Anthera Pharmaceuticals, Inc.

Read more...

Be the first to comment - What do you think?
Posted by admin - February 7, 2013 at 10:29 pm

Categories: Uncategorized   Tags: , , , , , , ,

Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit

HAYWARD, Calif., Nov. 28, 2012 /PRNewswire/ – Anthera Pharmaceuticals, Inc

Read more...

Be the first to comment - What do you think?
Posted by admin - November 28, 2012 at 1:00 pm

Categories: Uncategorized   Tags: , , , , , , ,

Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference

HAYWARD, Calif., Nov. 20, 2012 /PRNewswire/ — Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune …

Read more...

Be the first to comment - What do you think?
Posted by admin - November 20, 2012 at 10:00 pm

Categories: Uncategorized   Tags: , , , , , , ,

Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP …

HAYWARD, Calif., Nov. 1, 2012 /PRNewswire/ – Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune …

Read more...

Be the first to comment - What do you think?
Posted by admin - November 1, 2012 at 12:00 pm

Categories: Uncategorized   Tags: , , , , , , ,